OptiNose, Inc.
OptiNose, Inc. Fundamental Analysis
OptiNose, Inc. (OPTN) shows strong financial fundamentals with a PE ratio of -4.92, profit margin of -55.65%, and ROE of 44.78%. The company generates $0.0B in annual revenue with strong year-over-year growth of 10.20%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 31.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze OPTN's fundamental strength across five key dimensions:
Efficiency Score
WeakOPTN struggles to generate sufficient returns from assets.
Valuation Score
ModerateOPTN shows balanced valuation metrics.
Growth Score
ModerateOPTN shows steady but slowing expansion.
Financial Health Score
ModerateOPTN shows balanced financial health with some risks.
Profitability Score
WeakOPTN struggles to sustain strong margins.
Key Financial Metrics
Is OPTN Expensive or Cheap?
P/E Ratio
OPTN trades at -4.92 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, OPTN's PEG of 2.58 indicates potential overvaluation.
Price to Book
The market values OptiNose, Inc. at -1.83 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -14.45 times EBITDA. This is generally considered low.
How Well Does OPTN Make Money?
Net Profit Margin
For every $100 in sales, OptiNose, Inc. keeps $-55.65 as profit after all expenses.
Operating Margin
Core operations generate -17.68 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $44.78 in profit for every $100 of shareholder equity.
ROA
OptiNose, Inc. generates $-19.83 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
OptiNose, Inc. generates limited operating cash flow of $-8.40M, signaling weaker underlying cash strength.
Free Cash Flow
OptiNose, Inc. generates weak or negative free cash flow of $-8.40M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.83 in free cash annually.
FCF Yield
OPTN converts -9.96% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-4.92
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.58
vs 25 benchmark
P/B Ratio
Price to book value ratio
-1.83
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.38
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-2.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.64
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.45
vs 25 benchmark
ROA
Return on assets percentage
-0.20
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How OPTN Stacks Against Its Sector Peers
| Metric | OPTN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -4.92 | 28.45 | Better (Cheaper) |
| ROE | 44.78% | 763.00% | Weak |
| Net Margin | -55.65% | -45265.00% (disorted) | Weak |
| Debt/Equity | -2.07 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 0.64 | 2795.60 | Weak Liquidity |
| ROA | -19.83% | -16588.00% (disorted) | Weak |
OPTN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews OptiNose, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
831.34%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
18.48%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-103.79%
Industry Style: Defensive, Growth, Innovation
Declining